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Exploring pathway interactions in insulin resistant
mouse liver
Thomas Kelder1,2*, Lars Eijssen1, Robert Kleemann3, Marjan van Erk2, Teake Kooistra3 and Chris Evelo1
Abstract
Background: Complex phenotypes such as insulin resistance involve different biological pathways that may
interact and influence each other. Interpretation of related experimental data would be facilitated by identifying
relevant pathway interactions in the context of the dataset.
Results: We developed an analysis approach to study interactions between pathways by integrating gene and
protein interaction networks, biological pathway information and high-throughput data. This approach was applied
to a transcriptomics dataset to investigate pathway interactions in insulin resistant mouse liver in response to a
glucose challenge. We identified regulated pathway interactions at different time points following the glucose
challenge and also studied the underlying protein interactions to find possible mechanisms and key proteins
involved in pathway cross-talk. A large number of pathway interactions were found for the comparison between
the two diet groups at t = 0. The initial response to the glucose challenge (t = 0.6) was typed by an acute stress
response and pathway interactions showed large overlap between the two diet groups, while the pathway
interaction networks for the late response were more dissimilar.
Conclusions: Studying pathway interactions provides a new perspective on the data that complements
established pathway analysis methods such as enrichment analysis. This study provided new insights in how
interactions between pathways may be affected by insulin resistance. In addition, the analysis approach described
here can be generally applied to different types of high-throughput data and will therefore be useful for analysis of
other complex datasets as well.
Background
Biological pathways provide a powerful medium to
explore and reduce the complexity of large datasets.
Pathways organize genes, proteins, metabolites and their
interactions into functional groups, often visualized as
diagrams or networks. A commonly employed analysis
technique using pathways is enrichment analysis, where
pathways are represented as gene sets and where the
aim is to find those sets that are enriched with entities
of interest, such as differentially expressed genes [1].
More recent techniques also include connectivity within
a pathway to measure its impact [2]. Such techniques
allow a researcher to get an overview of biological pro-
cesses that are likely to play a role in the studied phe-
nomenon. The result of enrichment analysis is a sorted
list of pathways, which is easier to interpret than a list
of thousands of individual significantly expressed genes.
However, each pathway in this list is presented as an
isolated entity, while in reality these pathways can inter-
act, for example through interacting or shared proteins
and metabolites. To aid further exploration and inter-
pretation of gene set enrichment results, it would be
useful to get insight in possible relations or interactions
between pathways and how these are affected in the
context of the studied phenotype.
One way to get insight in possible relationships
between pathways is to look at their overlap in gene,
protein or metabolite content. Pathways with a high
overlap might be related by shared paths. Tools such as
ClueGO [3] and EnrichmentMap [4] allow the user to
convert the list of enriched pathways into a network by
calculating overlap between the sets. We used another
approach with bi-partite graphs to create a network
based on overlap in significantly regulated genes [5].
* Correspondence: thomaskelder@gmail.com
1Department of Bioinformatics, Maastricht University, Maastricht, The
Netherlands
Full list of author information is available at the end of the article
Kelder et al. BMC Systems Biology 2011, 5:127
http://www.biomedcentral.com/1752-0509/5/127
© 2011 Kelder et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Another more functionally based approach is to find
possible pathway cross-talk by looking at protein inter-
actions between pathways. Cross-talk allows multiple
pathways to exchange signals and influence each other.
For example, the P53 pathway can control the Cell
Cycle pathway by regulating the expression of p21 and
can itself be activated by several pathways, for example
the MAPK pathway. Metabolic pathways may share
enzymatic reactions and may influence each other by
influencing the availability of a substrate. These forms
of pathway cross-talk are highly context dependent, for
example, interactions between the P53 pathway and Cell
Cycle depend on several external stress factors such as
DNA damage or oxidative stress. Previous studies have
already explored this idea [6,7] by building a pathway
cross-talk network based on direct interactions between
the proteins in the pathways. Both studies were based
on the assumption that a pair of pathways is likely to
interact when a higher number of protein-protein inter-
actions are found between them than would be expected
by chance. The work of Li et al. resulted in a scale-free
pathway cross-talk network in which pathways in the
same broad functional category indeed cluster together.
Transcriptomics data was integrated into this network
by finding cliques (a subset of pathways in which every
two pathways are connected) which contained highly
enriched pathways. Huang et al. performed a similar
study, but also considered overlapping proteins between
the pathways and integrated transcriptomics data at the
protein level by counting only interactions between pro-
teins encoded by differentially expressed genes. This
resulted in context specific networks, reflecting interac-
tions between pathways within the context of the
dataset.
In this study, we investigate interactions between
pathways by finding regulated paths between pathways
for a given transcriptomics dataset. While the methods
of Li et al. and Huang et al. only consider direct protein
interactions between pathways, considering paths span-
ning multiple interactions may detect indirect interac-
tions as well. Indirect interactions consist of paths
including one or more proteins that are not annotated
to a pathway, but do have known interaction or binding
partners. In case the majority of the genes encoding
these proteins and their interacting partners in two dif-
ferent pathways would be differentially expressed in a
given condition, this indicates a potentially relevant path
through which these pathways interact. An algorithm to
detect pairs of pathways that contain such a path would
allow researchers to directly explore and visualize possi-
ble paths along which pathways might interact in a
given context. Furthermore, the inclusion of proteins
that have not yet been annotated to a pathway in the
analysis makes it possible to look beyond well studied
processes, increasing the chance of generating novel
hypotheses.
We designed a method to detect both direct and
indirect interactions between pathways and visualize the
resulting paths and applied this method to a transcrip-
tomics dataset from the European Nutrigenomics Orga-
nization (NuGO) PPS2 study [8] to investigate the
response to a glucose challenge in liver samples from
obese and insulin resistant, as well as normal mice.
Insulin resistance is a complex disease, not limiting to
metabolism, but also associated to for example inflam-
mation [9]. Interactions between different pathways
might be especially relevant in the context of such com-
plex phenotypes. Using this dataset, we hope to gain
insight in the regulated biological processes during the
response to the metabolic stressor glucose and the influ-
ence of a pretreatment with a high-fat diet on this
response.
Results
A novel approach to explore pathway interactions
To find potentially regulated paths between different
pathways, we designed a method based on non-redun-
dant shortest paths in a weighted graph. The required
input data are:
1. A set of pathways, each pathway consisting of a col-
lection of gene, protein and/or metabolite entities.
2. An interaction network, providing interactions or
functional associations between genes, proteins and/or
metabolites, which can be compiled from different
resources.
3. A weight value for each edge in the interaction net-
work, indicating how much an edge will contribute to
the length of a path. This can be based on experimental
data, for example the expression of the genes that the
edge connects.
We will now briefly introduce the approach. For a
more complete description of the procedure we refer to
the methods section. For each pathway pair, a score is
calculated by finding the set of non-redundant weighted
shortest paths that have a length which is smaller than a
given threshold and do not cross any other pathway.
Non-redundant paths are used to identify the different
routes of information transfer between the pathways.
The length of each path is defined by the sum of the
edge weights in the path. By assigning a lower weight
for edges between nodes for which the corresponding
genes are more differentially expressed in the dataset,
paths that include regulated genes will get a shorter
length. The score for a pathway pair depends on the
number of paths found and their length (Figure 1C).
The more and shorter the paths found between two
pathways, the more likely it is that they interact and the
higher the score. A pathway network is generated by
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creating an edge between a pathway pair if the p-value
based on the score of that pair (see methods) is smaller
than a given significance threshold.
This method was applied to pathways from the Wiki-
Pathways [10] and KEGG databases [11], which after
merging strongly overlapping pathways resulted in a set
of 236 pathways covering 6953 genes. A directed inter-
action network was generated based on reactions in
these pathways and extended with reactions, functional
associations between proteins, protein-protein interac-
tions and transcription factor targets from several public
databases (see methods). The resulting interaction net-
work consisted of 6893 proteins and 138,105 interac-
tions. Because a subset of interactions in this network
have a specified direction (e.g. transcription factor tar-
gets), the identified interactions between pathways are
directed as well.
Application to an insulin resistance dataset
Pathway interactions were investigated in the context of
a transcriptomics dataset of mouse liver samples. This
dataset contains gene expression measurements before
(t = 0) and at 0.6 hour (t = 0.6), 2 hours (t = 2) and 48
hours (t = 48) after a glucose challenge in two groups of
mice fed either a low fat (LF) or high fat (HF) diet for
12 weeks before the challenge. After these 12 weeks all
mice fed with HF diet had become obese and had devel-
oped insulin resistance [12]. To test for differential gene
expression between different groups, in total 7 compari-
sons were made. Firstly, to determine the baseline effect
of the different diets on gene expression, the measured
genes were tested for differential expression between the
HF and LF samples at t = 0. Secondly, to determine the
changes in gene expression following the glucose chal-
lenge in each individual diet group, the genes were
tested for differential expression between t = 0 and each
other time point (t = 0.6, t = 2 and t = 48 hours). Each
comparison resulted in a T-statistic for every gene
representing the significance and direction of differential
expression. The number of differentially expressed genes
(q < 0.01) is shown in Table 1. For the number of differ-
entially expressed genes in the glucose challenge
response, the two diet groups display a different trend.
In the LF group, the number of significant genes grows
over time and is highest at t = 48, indicating that even
48 hours after the challenge gene regulation has not
Figure 1 Overview of the analysis approach to investigate interactions between pathways. A: Information from different resources and
experimental data is integrated into a weighted gene/protein interaction network and a set of pathways and their associated genes and
proteins. B: Based on the interaction network, an interaction score and significance is calculated for each pathway pair. C: Example of the process
of identifying a set of non-redundant shortest paths for the interaction of pathway P1 to P2. This panel shows step 5-7 of the calculation as
described in the Methods section. D: Two representations of the resulting pathway interactions. The top panel shows the pathway interaction
network, where each edge represents a significant interaction between two pathways. The bottom panel shows a detailed network showing the
identified shortest paths between pathways P1, P4 and P2.
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returned to the initial situation. However, in the HF
group, the number of significant genes peaks at t = 2
and decreases again at t = 48. For each of the compari-
sons, pathways were identified that were enriched with
differentially expressed genes (Additional file 1, Figure
S1 and Table 1). The trend observed with respect to the
number of differentially regulated genes in response to
the glucose challenge is not apparent in the number of
enriched pathways. Both the LF and HF groups show an
increasing trend, where the number of enriched path-
ways at t = 48 is higher than preceding time points in
both groups.
Edge weights were derived from the computed gene-
level T statistics of the comparisons to generate a
weighted interaction network for each comparison (see
methods). The number of edges in each interaction net-
work that have a weight smaller than the maximum
path length (see methods) and hence may contribute to
a path between two pathways is shown in Table 1.
These edges cover between 3.5% and almost 19% of the
complete interaction network. The algorithm to detect
pathway interactions was run for each comparison,
resulting in 7 pathway interaction networks. A Cytos-
cape [13] session file that contains an interactive visuali-
zation for each network is available as Additional file 2.
The results of the algorithm can be represented as two
different types of networks (Figure 1D). First are the
pathway interaction networks that provide a global over-
view of how pathways might relate without showing the
underlying protein interactions. Hence, each node in
this pathway interaction network represents a pathway
and each edge is a significant interaction between them.
Second are detailed networks that also show the protein
interactions that compose the paths between the path-
ways. These networks consist of two types of nodes,
representing either a pathway or a protein. An edge
between a pathway node and protein node represents
association of the protein to the pathway and an edge
between two protein nodes represents an interaction
between these proteins. The next section provides an
analysis of the generated pathway interaction networks
by identifying pathways with a more central role in the
network. This is followed by a global analysis of the pro-
tein interactions that form these pathway interactions, to
identify proteins that may play an important role in
pathway-crosstalk in this dataset. Finally, several poten-
tially interesting pathway interactions will be highlighted
and investigated more closely by zooming in to their
protein interactions via the detailed network
representation.
Global analysis of the generated pathway interaction
networks
The number of identified pathway interactions ranges
from 25 to 207 across the different networks (Table 2).
The differential expression between the HF and LF
groups at t = 0 (before glucose challenge, but after 12
weeks of diet intervention) results in the most interac-
tions, while the early response to the glucose challenge
in the LF group results in the fewest interactions. For
66.7% of the pathways enriched with differentially
expressed genes between the diet groups at t = 0, at
least one significant interaction with another pathway
could be found. This number is much lower for the
early response to the glucose challenge in the LF group
(20% and 27.9%) and HF group at t = 0.6 (23.1%).
To identify potential focal pathways in the network,
we can look at several node centrality measures. Addi-
tional file 1, Figure S2 shows the degree (number of
interactions with other pathways) of the most connected
pathways. Since the pathway interactions are directional,
we can make the distinction between in-degree and out-
degree. A pathway with a high in-degree is the target of
many pathway interactions, which may indicate that the
pathway is strongly regulated. A pathway with a high
out-degree is the source of many pathway interactions,
which may indicate a role in regulation of different tar-
gets. The three pathways with the highest in-degree for
the network resulting from the comparison between
diets at t = 0 are three stress response and apoptosis
Table 1 Gene and pathway statistics for each comparison
Comparison Significant genes, q < 0.01 Enriched pathways, p < 0.05 Edges with weight < = lmax
HF vs LF, t = 0 1971 (17.3%) 54 (22.9%) 24055 (16.8%)
LF t = 0 vs t = 0.6 24 (0.2%) 17 (7.2%) 5054 (3.5%)
LF t = 0 vs t = 2 573 (5.0%) 43 (18.2%) 13251 (9.2%)
LF t = 0 vs t = 48 1607 (14.1%) 57 (24.15%) 20220 (14.1%)
HF t = 0 vs t = 0.6 773 (6.7%) 13 (5.5%) 15784 (11.0%)
HF t = 0 vs t = 2 2815 (24.7%) 17 (7.2%) 26845 (18.7%)
HF t = 0 vs t = 48 736 (6.4%) 40 (17.0%) 16857 (11.7%)
Number of significant genes, enriched pathways and edges in the interaction network that have a weight shorter than the maximal path length and hence
contribute to the pathway interactions. Percentages are relative to the total number of measured genes, the total number of pathways and the total number of
edges in the interaction network respectively.
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related pathways: Oxidative damage and apoptosis (14
interactions), FAS pathway and stress induction of
HSP70 (14 interactions) and Apoptosis and its regula-
tion by HSP70 (10 interactions). The first two pathways
share 11 neighbors among their incoming interactions
and 7 neighbors are shared among all three pathways.
Interestingly, 5 of these 7 shared neighbors are in the
top pathways with highest out-degree and 4 of those are
also enriched with differentially expressed genes (p <
0.05). For most of the pathways with the highest in-
degree, the out-degree is zero or very low and the corre-
sponding node is acting like a sink, or end point. The
same holds the other way around, where pathways with
the highest out-degree tend to act as a source. To find
pathways that may have a gatekeeper role in the net-
work, we can look at the betweenness centrality, which
measures how often a pathway occurs on shortest paths
between the other pathway nodes in the network. The
higher the betweenness, the more the pathway can con-
trol interactions between other pathways in the network.
Additional file 1, Figure S3 shows the betweenness cen-
trality of the pathways with highest betweenness. Nota-
ble are the many cytokine related pathways that all have
a high betweenness in the network for the response at t
= 2 in the HF diet group. None of these centrality mea-
sures seem to correlate with enrichment of the pathway
and a pathway does not have to be enriched with
differentially expressed genes to exhibit a central posi-
tion in the pathway interaction network.
Protein interactions contributing to regulated paths
between pathways
Studying the protein interactions and functional associa-
tions that form differentially regulated paths between
pathways may provide insights in the mechanisms of
interacting pathways and reveal potential key regulators
of pathway cross-talk that play a role in the dataset. The
number of paths contributing to each pathway interac-
tion network ranges from 52 for the smallest network
(LF response at t = 0.6) to over 1500 for the largest
(comparison between diets at t = 0). Most paths consist
of direct interactions between proteins in the interacting
pathways (Additional file 1, Figure S4). Only 17% of the
paths over all networks are indirect and have one inter-
mediate protein, while only 1 path has two intermediate
proteins. The network for the response in the LF group
at t = 48 consists of almost 50% of indirect paths, a con-
siderably larger part than the other networks.
There is a lot of overlap among the paths between
pathways, since the number of unique protein interac-
tions that form these paths is much lower than the
number of paths itself (Table 3). For example, for the
comparison between the diet groups at t = 0, the 1562
paths between pathways are formed by only 440
Table 2 Statistics for each pathway interaction network
Comparison Nodes (pathways > = 1 interaction) Enriched nodes Edges
(p < 0.001)
HF vs LF, t = 0 123 (52.1%) 36 (66.7%) 207
LF t = 0 vs t = 0.6 17 (7.2%) 5 (20.0%) 25
LF t = 0 vs t = 2 57 (24.2%) 12 (27.9%) 52
LF t = 0 vs t = 48 82 (34.8%) 27 (47.4%) 108
HF t = 0 vs t = 0.6 43 (18.2%) 3 (23.1%) 54
HF t = 0 vs t = 2 111 (47.0%) 10 (58.8%) 160
HF t = 0 vs t = 48 82 (34.8%) 19 (47.5%) 92
The first column shows the comparison for which the network is generated. The second column shows the number of pathways in the network that have at
least one significant interaction. The third column shows the number of pathways from the second column that are also enriched. The last column shows the
number of significant pathway interactions. Percentages are relative to the total number of pathways and total number of enriched pathways respectively.
Table 3 Unique proteins and protein interactions between pathways for each network
Comparison Unique protein interactions Number of unique proteins Unique proteins not in a pathway
HF vs LF, t = 0 440 198 25
LF t = 0 vs t = 0.6 8 6 0
LF t = 0 vs t = 2 47 43 1
LF t = 0 vs t = 48 275 142 14
HF t = 0 vs t = 0.6 53 47 0
HF t = 0 vs t = 2 400 200 18
HF t = 0 vs t = 48 118 86 2
Number of unique proteins and protein interactions that contribute to the paths between pathways for each network.
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unique protein interactions. The high overlap of pro-
tein interactions in the paths between pathways indi-
cates the presence of proteins that are involved in
multiple paths and might act as key regulators of path-
way interactions. Additional file 1, Table S1 shows the
proteins that are involved in most pathway interactions
per network. Most of these proteins participate in
interactions with highly connected pathways and a
large part is involved in well-known signaling pro-
cesses such as Kras and Mapk1, transcription factors
such as Jun and cytokines such as Il1a and Il1b. There
is some overlap of these proteins between the different
networks, but there are no proteins that are in the top
ten for each time point. One protein that plays a sig-
nificant role in multiple networks is Pik3r1, which is
known to play a role in insulin signaling by activation
through IRS-1 [14] and participates in most of the
paths for the networks for the response in the HF
group at t = 2 and t = 48.
Proteins that act as intermediate in indirect interac-
tions between pathways are of special interest. They
are not annotated to any pathway yet, while they do
seem to play a role in the context of this dataset, so
studying their interactions may lead to new findings
that would have been missed by looking at the annota-
tions in the pathways alone. Table 3 lists the number
of such proteins per network. Interestingly, while the
network for LF at t = 48 contains relatively many
indirect interactions, the number of proteins playing a
role in indirect interactions is lower than expected.
Upon closer inspection, the high number of indirect
paths is mainly due to binding interactions of a single
set of proteins (including differentially expressed
Mapre3, Cep57, Tubg1 and Nedd1) that are not anno-
tated to a pathway, but do all bind to a few proteins
that play a role in many different pathway interactions,
such as Ywhab, Prkaca, Tubb5 and Hsp90ab1. One of
the proteins that is not annotated to any pathway is
Sgk3 which plays a role in several pathway interactions
for the response to the glucose challenge in the LF
diet group at t = 2 and t = 48 (Additional file 1, Figure
S5) as well as the comparison between the diet groups
at t = 0 (Figure 2). In the latter, Sgk3 interacts with
Gsk3b and Tsc1 to form one of the paths that form the
identified interaction between the Axon guidance and
Insulin signaling pathways. The genes encoding for
these three proteins are all down-regulated in the HF
diet group (q < 0.01). Since Gsk3b is present in both
the Axon guidance and Insulin signaling pathways, in
addition to the possible interaction between the two
pathways via Sgk3, it might also form an alternative
route within the Insulin signaling pathway that has
been differentially regulated in the HF diet group (Fig-
ure 2).
Visual exploration of the pathway interaction networks
The pathway interaction networks might be powerful
tools for interactive exploratory analysis, by browsing
and filtering the network visualizations in different ways
to find interesting structures. The structural properties
discussed above may guide to the most relevant parts of
each network, which can then be explored in more
detail. In this section we highlight several notable path-
way interactions for each network and investigate the
protein interactions that form the paths between the
pathways.
Differential expression between the LF and HF group
The network for the comparison between the diet
groups at t = 0 may provide insight in the changes con-
tributing to and resulting from the development of insu-
lin resistance after feeding of a HF diet. Due to the large
size of this network, and to aid visual exploration, we
only include pathway interactions for which at least one
of the participating pathways is significantly enriched (p
< 0.05) with differentially expressed genes. Based on this
filtered network, we study several potentially interesting
interactions and subgraphs. A good starting point for
this exploration might be the 3 apoptosis and stress
response related pathways that have the highest in-
degree in the network. Interestingly, 8 out of 14 path-
ways interacting with at least one of the three apoptosis
related pathways also have an incoming interaction from
the ESC pluripotency pathway, which is significantly
enriched (p < 0.01). This pathway has a strong interac-
tion (consisting of 38 paths) with the Proteasome path-
way, which is also significantly enriched (p < 0.01). The
remaining pathways interacting with the 3 apoptosis
related pathways include 4 pathways with a relatively
high out-degree of which 3 are significantly enriched (p
< 0.05), and two versions of the Wnt signaling pathway,
which both have a strong connection (25 and 27 paths)
with the significantly enriched TNF-alpha NF-kB Signal-
ing Pathway (p < 0.05). The subgraph containing these
pathways and their interactions is shown in Figure 3A.
Based on this subgraph, we can “zoom in” to view the
individual protein interactions that comprise the paths
between the interacting pathways. For example, the
paths between the 3 apoptosis related pathways and
their neighbors are shown in Figure 3B. Despite the
many neighbors of these three pathways, the number of
unique proteins in these neighbors contributing to the
interaction is relatively low (15 proteins for 14 path-
ways) and hence many of these proteins are annotated
to more than one of the source pathways. This indicates
the presence of common paths, shared by different path-
way interactions. Indeed, there seem to be two main
paths shared across different pathway interactions.
Firstly, Raf1, Kras, Nras and Prkcb are present in more
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than 10 of the source pathways and all form a path to
the three target pathways via Map3k1, which partici-
pates in 53 paths between the pathways. Secondly, there
is a distinct path through Prkar1a, which forms an
interface to the Gap junction, Long term depression and
Wnt signaling pathway via indirect binding interactions
with Ppp2r1a, Tuba4a and Tubb5. Ppp2r1a may also
play a role in the interaction with the TNF-alpha NF-kB
Signaling pathway and two versions of the Wnt pathway
via indirect binding interactions with Ywhab (Additional
file 1, Figure S6C). Since this is an indirect interaction,
involving proteins that have not been annotated to one
of the pathways, this is a target for further study to
elucidate the potential role of these proteins in interac-
tion between these two pathways. The link between the
Proteasome and ESC pluripotency pathway can be lar-
gely explained by interactions between differentially
expressed subunits of the proteasome and Gsk3b, Apc
and Ctnnb1 (beta-catenin). The pathway diagram of the
ESC pluripotency pathway (Additional file 1, Figure S7)
reveals that these interactions are part of Wnt signaling
and can influence the concentration of beta-catenin by
targeting it for proteolysis after phosphorylation by
Gsk3b and Apc. Interestingly, Ctnnb1 and Gsk3b are
also present in other interactions, connecting the TNF-
alpha NF-kB signaling pathway to the Wnt signaling
Figure 2 An indirect interaction between the Axon Guidance and Insulin Signaling pathways in the network for the comparison
between HF and LF diet at t = 0. Left: Network representation of the identified path between the two pathways, consisting of three proteins
Gsk3b, Sgk3 and Tsc1. Right: The location of these proteins in the KEGG pathway diagrams. The newly found indirect interactions have been
added in red.
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Figure 3 Pathway interactions and detailed network visualization for the interactions with three apoptosis related pathways for the
comparison between HF and LF diet at t = 0. A: Subgraph of the pathway interaction network, based on incoming interactions to three
stress response and apoptosis pathways with the highest in-degree. Pathway nodes with a thick border are significantly enriched (p < 0.05) with
differentially expressed genes. B: The protein interactions that compose the interactions between the three apoptosis related pathways and their
neighbors in the subgraph as shown in box A (see inset, included interactions are colored orange). Protein nodes have a thick border when
their encoding genes are significantly differentially expressed (q < 0.05).
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pathways, the B-cell and T-cell receptor pathways to the
Oxidative damage and apoptosis pathways via Akt2,
Casp7 and Trp53, and the ESC pluripotency pathway to
the B-cell and T-cell signaling and Chemokine signaling
pathways via Crk, Nfatc2 and Chuk.
In addition to the pathways with a high degree, the
network contains a potentially interesting component
consisting of 10 metabolic pathways for which interac-
tions with the Primary bile acid biosynthesis and Peroxi-
some pathways have been found. Out of the 12
pathways in this component, 9 are significantly enriched
(p < 0.05). When looking at the protein interactions that
form the interactions between these pathways, it turns
out to be comprised of two binding interactions
between Hadh, Hsd17b10 and Hsd17b4 (Additional file
1, Figure S7). These binding interactions are assigned by
the STRING database [15] as subunits of a single
enzyme complex, but in reality they are three distinct
isozymes of 3-hydroxyacyl-CoA dehydrogenase [16,17].
Therefore, these proteins are probably not binding, but
rather catalyzing a similar reaction in each of these
pathways. While these proteins are differentially
expressed and may play a role in insulin resistance and
response to HF diet, they are not likely to contribute to
an interaction between these pathways.
Early response to the glucose challenge
The networks based on differential expression between t
= 0 and each other time point after the glucose chal-
lenge in the LF group provide insight in pathway inter-
actions that play a role during the response to the
glucose bolus in mouse liver. The low differential
expression at t = 0.6 in the LF group (only 24 significant
genes, q < 0.05) is reflected in the small size of the cor-
responding network. Studying the protein interactions
for that network reveals that all identified pathway inter-
actions include Jun and Fos, for which the gene expres-
sion has both increased more than 5-fold compared to t
= 0, and Il1b with a 2.5 fold increase (Additional file 1,
Figure S8). Part of the interactions also includes Il1a,
which is differentially expressed with a more than 2-fold
increase. As a dimer, Jun and Fos form the AP-1 tran-
scription factor, which responds to several stimuli
including cytokines and controls several processes such
as apoptosis and proliferation, for all of which related
pathway interactions are identified. The network for the
HF group at t = 0.6 shows a high overlap with the cor-
responding network for LF, including almost all edges of
the LF network. The protein interactions and expression
of Jun and Fos in the network for HF are similar to
those in LF (Additional file 1, Figure S8), indicating that
these interactions via AP-1 remain unaffected by obesity
and insulin resistance. However, two additional interac-
tions with the down regulated genes Irak4 and Il12a
exist, suggesting a reduced capability to mount an
inflammatory response since both factors are critically
involved in innate immune responses. In addition to the
largest component of the network for HF at t = 0.6,
which is largely spanned by the interactions with Jun
and Fos, there are several small components of isolated
interactions between two or three pathways, which are
not present in the LF network.
One of the components of the HF network at t = 0.6
that is not present in LF, for example, is composed of
the Antigen processing and presentation and Spliceo-
some pathways, both interacting with the Lysosome
pathway. These interactions have been identified
because two genes encoding for proteins of the HSP70
family, Hspa1a and Hspa1b, are differentially expressed
(> 4 fold) and interact with Ap1s1, Ap1b1 and Cltc.
These proteins are involved in transport of lysosomal
enzymes and show moderate, but not significantly differ-
ential expression (Additional file 1, Figure S9). Another
potentially interesting component that consists of three
pathways provides an interaction between the S1P
receptor pathway, the Ribosomal proteins pathway and
Insulin signaling pathway via Mapk7, Nr4a1 and Sgk1,
which are all significantly up-regulated compared to t =
0 (Additional file 1, Figure S10), and Rps6kb2, which is
up-regulated albeit not significantly (q = 0.066). Based
on the pathway diagram, Mapk7 is a downstream target
of the S1P receptor pathway, but because the other pro-
teins in this pathway do not show significantly differen-
tial expression, it does not seem likely that the
differential expression of Mapk7 is related to upstream
activities in this pathway. However, since Mapk7 is pre-
sent in the insulin signaling pathway as well, this might
point to an alternative path within the insulin signaling
cascade, which may be affected by HF diet in response
to the glucose challenge.
The networks for t = 2 show much more difference
between the HF and LF diet. There are only two over-
lapping pathway interactions and in addition, the net-
work for LF is much less connected. A large part of the
connectivity in the HF network situates around the
merged version of the Cytokine-cytokine receptor inter-
action pathway and Cytokines and inflammation path-
ways (Cytokine pathway), which has the highest
betweenness centrality. Several receptors listed in this
pathway are differentially expressed, such as Il1r1 and
Il1r2, involved in a path to Apoptosis and oxidative
stress via Casp8 and Casp9. All other receptors that
contribute to the pathway interactions, including up-
regulated Igf1r, Erbb3, Egfr and down-regulated Kdr and
Fgfr4, are receptor tyrosine kinases and form a path to
several specific interleukin signaling pathways, T-cell
and Kit receptor pathways via the Cbl protein. Cbl is a
ubiquitin-protein ligase that can target these receptors
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for endocytosis [18]. Its expression profile shows a peak
at t = 2 in the HF group only, where the expression has
increased almost 2-fold compared to t = 0. We also
found that the Endocytosis pathway, which indeed con-
tains Cbl and the receptor tyrosine kinases as well,
shares all its interacting pathways with the Cytokine
pathway. In addition to Cbl, the interactions between
the Endocytosis pathway and its neighbors also include
the up-regulated Cltc and Cltb, which encode for the
two light chains of clathrin, as well as several other pro-
teins that are involved in clathrin dependent endocytosis
(Additional file 1, Figure S11). This endocytosis mechan-
ism is known to be responsible for transporting receptor
tyrosine kinases to the endosome after ubiquination by
Cbl [18]. Together, these interactions indicate that
removal of these receptors from the cell membrane is
affected at this point in the glucose challenge in the HF
diet group specifically.
Late response to the glucose challenge
A notable aspect of the late response to glucose chal-
lenge is that the LF group contains many more differen-
tially expressed genes than at the early time points,
while in the HF group the number peaks at t = 2 and is
lowest at t = 48. This difference is not reflected in the
pathway interaction networks for t = 48, which both
contain almost the same number of nodes and edges.
However, the overlap between these networks is small;
only 4 edges are present in both networks, including the
interaction between the TGF-beta receptor signaling
Pathway and Proteasome. Interestingly, the proteins in
the paths between these two pathways with the TGF-
beta and Proteasome pathways behave differently
between the HF and LF group (Additional file 1, Figure
S12). All genes encoding the participating proteins in
the Proteasome pathway are down-regulated in the LF
network and up-regulated in the HF network. The pro-
teins Cdc27 and Ctnnb1 in the TGF-beta pathway show
a similar pattern. The interaction in the LF network
contains another protein, Axin1, which is significantly
up-regulated in the LF group and slightly down-regu-
lated in the HF group is not included in the latter inter-
action due to its low significance.
The network for the LF group contains one tightly
connected cluster, held together by the Antigen proces-
sing and presentation and T Cell receptor signaling
pathways, including interactions with the enriched Cell
cycle and TNF-alpha NF-kB signaling pathways. There
are several central proteins in these interactions, includ-
ing a set of shared binding partners between Ywhab in
the Cell cycle and TNF-alpha pathways and Tubb5 in
the T Cell Receptor pathway, or Hsp90ab1 in the Anti-
gen processing pathway (Additional file 1, Figure S13).
The Gab1 protein in the TNF-alpha pathway directly
interacts with several proteins in the T Cell pathway,
including the down-regulated Fyn and Sos2, and up-
regulated Pik3r2 and Pxn. In addition, Prkaca is present
in most neighbors of the Antigen processing and pre-
sentation and T Cell receptor signaling pathways, mak-
ing it the protein involved in most paths for this
network. Another interesting structure in the network is
the second order neighborhood of the Insulin signaling
pathway, containing the Wnt and Il-6 signaling path-
ways and the Starch and sucrose metabolism pathway,
which are all significantly enriched (Additional file 1,
Figure S14). A large part of the involved proteins are
present in multiple of these pathways. For example, half
of the proteins of the IL-6 pathway are also present in
the Insulin signaling pathway. One of the proteins pre-
sent in both the Wnt and IL-6 pathways, Gsk3b, forms
an indirect path to the Insulin signaling pathway via
Sgk3 which interacts with Trib3 and Tsc1, as well as a
direct interaction via Tsc1. Two enzymes Pygl and Gys2
participate in the interactions with the Starch and
sucrose metabolism pathway, interacting with several
proteins in the Insulin, IL-6 and Wnt signaling path-
ways, which might indicate activated mechanisms that
regulate these enzymes. The up-regulated Pygl gene
encodes for glycogen phosphorylase which catalyzes the
rate-limiting step in glycogen degradation. The down-
regulated Gys2 gene encodes for glycogen synthase,
involved in conversion from glucose to glycogen.
Together, this indicates that at t = 48 the liver switches
from storage of excess glucose to usage of the stored
glycogen, possibly influenced by the pathway interac-
tions identified here. The pathway interaction network
for the HF response is typed by several key proteins
including Pik3r1, Kras, and Ctnnb1. Kras and Ctnnb1
both have a protein interaction with Pik3r1 which plays
a key role in many of the identified pathway interactions
in this network. In addition, the up-regulated protein
Mapk14 also interacts with Kras and 8 out of 12 path-
ways that contain Mapk14 also contain Pik3r1.
Discussion
The goal of this study is two-fold. Firstly, we aimed to
design methods for exploring possible pathway interac-
tions in a specific context, which can be defined by an
experimental dataset. Secondly, we explored pathway
interactions relevant to glucose response in mouse liver
and how these interactions are affected by high fat feed-
ing-induced insulin resistance. We will first highlight
several of the identified interactions and follow with a
discussion about the described approach in general.
The high number of interactions with three apoptosis
related pathways in the network for the comparison
between diets at t = 0 suggest involvement of apoptosis
in insulin resistant liver. Even though these pathways
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are not enriched with differentially expressed genes, they
are the end point of many pathway interactions from
upstream signaling pathways, which suggests that apop-
tosis is differentially regulated in the insulin resistant
mice. Indeed, a relation between apoptosis and insulin
resistance has been described before [19] and recent stu-
dies have shown that apoptosis might be increased in
insulin resistant liver in humans [20,21]. The proteins
identified could help to find mechanistic explanation for
this observation, but it is hard to identify the most cru-
cial step based on transcriptomics data alone, since
many of the signaling events take place via post-tran-
scriptional modifications.
The response to the glucose challenge at t = 0.6 in
both LF and HF is characterized by the up-regulation of
Jun and Fos, together forming the transcription factor
AP-1, and Il1a and Il1b. This might indicate that AP-1
initiates several processes in the early response to glu-
cose, possibly activated by Il1, and that this mechanism
is not influenced by obesity or insulin resistance. A pre-
vious study has demonstrated that Il1 might indeed acti-
vate AP-1 in a hepatocyte cell line [22]. Immediate early
genes such as Jun and Fos are genes that are activated
transiently and rapidly in response to a wide variety of
cellular stimuli, including glucose [23]. They represent a
standing response mechanism that is activated at the
transcription level in the first round of response to sti-
muli, before any new proteins are synthesized. Our
interaction network contains 7 target genes of AP-1, of
which 4 are present in the dataset, but none are differ-
entially expressed during the early response. A possible
cause might be that AP-1 is not activated and therefore
its expression has no consequences, however we cannot
determine this with the current dataset. Because of the
general role of AP-1, there are probably more targets
than annotated in our interaction network, so it may be
of interest to analyze this effect in more detail using
more specialized bioinformatics approaches or identify
possible targets in a follow-up experiment. In addition
to this shared mechanism, we also identified several
interactions unique for the HF group.
First, the expression of two proteins of the HSP70
family show a distinct peak of over 4-fold increased
expression at t = 0.6 in the HF group, but not in the LF
group. We identified a possible interaction of these pro-
teins with the Lysosome pathway that may indeed play a
role in this pathway by uncoating of clathrin-coated
vesicles [24]. However, based on our data it is hard to
judge the relevance of this finding, since the three pro-
teins in the Lysosome pathway that may interact with
the HSP70 proteins show only moderate, not signifi-
cantly differential expression at t = 0.6, their expression
profiles do not correlate, and only a few additional
genes in the Lysosome pathway itself show significantly
differential expression at t = 0.6. It may be more likely
that another function of these HSP70 proteins, for
example their role as chaperones, could be related to
their expression profile specific to the HF group. In
addition, one of the two HSP70 proteins, Hspa1a (also
known as HSP72), was found to play a role in prevent-
ing insulin resistance and blocking inflammation in
human muscle by preventing c-jun amino terminal
kinase (JNK) phosphorylation [25]. Since JNK can acti-
vate the c-Jun transcription factor, which was also found
to be differentially expressed at t = 0.6, there may be a
relation with the HSP70 proteins. Unfortunately neither
the pathway collection nor the interaction network we
used here contains any relevant interactions which are
altered at the transcriptional level and could provide
more insight in this possible relation.
Second, we identified an interaction between Mapk7,
Rps6kb and Sgk1 in the Insulin signaling pathway and
the transcription factor Nr4a1 in the Nuclear receptors
pathway. Both Nr4a1 and Sgk1 show an expression pro-
file with a peak at t = 0.6 in both the HF and LF group,
however Mapk7 and Rps6kb2 are only up-regulated in
the HF group. This difference might indicate the pre-
sence of an alternative mechanism through which
Nr4a1 can be activated. Nr4a1 is a known transcrip-
tional regulator of genes involved in glucose metabolism
in mouse liver [26]. Because of the absence of any tar-
gets for this transcription factor in our interaction net-
work we could not determine whether any downstream
interactions to the Insulin signaling pathway are
affected. Both the mRNA processing and Spliceosome
pathways are significantly enriched for the differentially
expressed genes at t = 0.6 and together with the pre-
sence of several differentially expressed transcription
factors and the HSP70 chaperones this indicates that
the response to the glucose challenge at t = 0.6 is
mainly typed by a stress response and possibly transcrip-
tional activation of genes to initiate the further response.
The most notable property of the pathway interaction
networks for the glucose response at t = 2 is the high
centrality of the Cytokine pathway. This pathway sum-
marizes different cytokines and their receptors, and
since several of these receptors are differentially
expressed it makes sense that this pathway fulfills a cen-
tral role in the network, by connecting to the different
processes these receptors play a role in. We identified a
regulated interaction between several cytokine receptor
pathways and the Endocytosis pathway, which might
point to increased removal of receptor tyrosine kinases
from the cell membrane in the HF group after ubiquina-
tion with the up-regulated Clb protein. Several of the
proteins participating in the interactions with the cyto-
kine receptor and Endocytosis pathways are known to
be related to insulin or even annotated to the Insulin
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signaling pathway. For example, Cbl plays an important
role in the CAP/Cbl/TC10 dependent transport of
GLUT4 vesicles [27]. This could point to an interaction
with the Insulin signaling pathway, but we did not iden-
tify a significant interaction in our network. Upon closer
inspection, however, an interaction with the Cytokine
receptor pathway has been found, but is just above our
significance threshold (p = 0.0018). This interaction
involves Cbl, Egfr and several other proteins in the Insu-
lin Signaling pathway, including three subunits of PI3K,
Crk and Igf1r. Although this interaction was not consid-
ered significant, it might be biologically relevant given
the high differential expression of Cbl and Egfr.
The switch from glycogen storage to glycogen break-
down observed at t = 48 can be expected after 48 hour
following the glucose challenge. However, the link with
the Insulin and Il-6 signaling pathways is interesting,
since the Il-6 signaling pathway has already been linked
to insulin actions and glycogen metabolism in vitro [28].
Another interesting observation is a difference in gene
expression between the HF and LF groups in the inter-
actions with the Proteasome pathway at t = 48, which is
possibly related to the TGF-beta pathway. Degradation
by the proteasome is an important mechanism in the
TGF-beta pathway [29], which may be affected in differ-
ent ways in the HF and LF groups. An identified inter-
action between the Wnt and Insulin signaling pathways
might also be related to the observed changes in expres-
sion in the proteasome pathway, since Gsk3b is involved
in degradation of beta-catenin by proteolysis, a process
which can be inhibited by Wnt stimulation to stabilize
beta-catenin, and which subsequently activates tran-
scription of target genes [30]. Inspecting the expression
profiles of Ctnnb1 and its associated proteasome related
genes shows a different expression in the LF compared
to the HF group at t = 48, so this mechanism could be
affected by diet in the late response to the glucose
challenge.
In summary, this analysis provided several new
insights in the pathway interactions underlying insulin
resistance in mouse liver and and the response to glu-
cose. Initially the LF and HF group showed very distinct
interactions with three apoptosis related pathways as
most highly connected in the HF group. Despite the
clear pathway and network differences in mouse livers
after 12 weeks of LF or HF diet feeding, the initial
response to a bolus of glucose is remarkably uniform
and Il1a, Il1b as well as well as the transcription factors
c-jun/fos (AP-1) appear to play an important role irre-
spectively of the degree of obesity and insulin resistance.
This observation is in line with reports showing that the
NLRP3 inflammasome senses glucose overload and trig-
gers IL-1b activation in a caspase-3 dependent way [31]
and suggests that this sensing mechanism is still active
under HF diet conditions. An interesting observation is
that there is much less overlap in the responses between
LF and HF at later time points (> t = 2) and that more
chronic types of inflammatory processes emerge. Of
note, the peak of differentially expressed genes is at t =
2 in HF and at t = 48 in LF suggesting that, in the
healthy state, the liver is able to cope with glucose over-
load by an extensive and permanent adaptation of its
gene expression program while in HF livers the meta-
bolic flexibility to switch the liver gene expression pro-
gram seems to be reduced and genes associated with the
TGF-beta pathway indicating liver stress and activation
of fibrosis pathways.
As illustrated in the analysis described here, the
method we developed is especially useful for exploring
large and complex datasets to find interesting aspects
and generate hypotheses. It can be used to add an extra
dimension to differential gene expression and pathway
enrichment results. Instead of redefining pathway
boundaries based on an interaction network, this
approach directly utilizes predefined pathways and
thereby complements the search for activated or regu-
lated genes and pathways by taking into account how
they may interact. These interactions between pathways
are not static and fixed, but are specific to the studied
context, providing a dynamic view on the pathway land-
scape. This approach allowed us to explore the NuGO
PPS dataset and identify relevant gene and protein inter-
actions. It also helped to hypothesize about underlying
mechanisms and possible downstream effects of certain
groups of differentially regulated genes, thereby provid-
ing starting points for more focused follow-up studies
or experiments.
During the analysis we mainly followed a fixed
approach to explore the pathway interactions consisting
of three main steps. First, we studied the pathway inter-
action network globally to identify highly connected or
central pathways and proteins in the network. This, for
example, pointed us to the apoptosis pathways in the
comparison between the two diet groups at t = 0, which
would not have been found by looking at pathway
enrichment alone. In the second step, we interactively
explored the interaction network using Cytoscape and
zoomed in to specific pathway interactions or subgraphs
by visualizing the protein interactions that form the
paths between the pathways. This step is partly guided
by the results of the previous step, since neighborhoods
of the central pathways or proteins often point to inter-
esting interactions. In addition, we looked for further
interactions based on pathways that are known or
expected to be involved in insulin resistance. For exam-
ple, this lead us to the interactions with the insulin sig-
naling pathways in the late HF response, which were
not central in the network but appeared to be relevant
Kelder et al. BMC Systems Biology 2011, 5:127
http://www.biomedcentral.com/1752-0509/5/127
Page 12 of 18
because of enrichment of all involved pathways and the
central role of insulin in this analysis. Finally, we often
referred back to the original pathway diagrams to
understand the context of the interacting proteins
within the pathway and look for any upstream of down-
stream effects (Figure 2). Together, these steps helped
us to better understand the generated pathway interac-
tion networks and the biology behind the transcrip-
tomics dataset.
In addition to the new perspective this analysis pro-
vides on the dataset, there are several advantages that
make this method a useful complement to existing path-
way analysis techniques. Firstly, compared to an analysis
limited to pathway annotations, this combinatory analy-
sis integrates additional information by using other
sources of protein interactions and allowing indirect
interactions including proteins that are not annotated to
any pathway. This extends the coverage of the analysis
with an additional 1660 genes that are in the interaction
network but not annotated to any pathway, of which
929 are available in our transcriptomics dataset. This
allowed us to move beyond well annotated knowledge in
pathways, while still benefiting from the framework of
canonical pathways and their intuitive visualizations.
While the interaction network we used here is still rela-
tively small compared to the number of interactions we
expect to exist, current developments in measuring pro-
tein interactions [32] and identifying transcription factor
targets [33] will further increase the coverage in the
future. Secondly, when focusing on enrichment of gene
sets or pathways alone, results might be missed since
pathways may be relevant or activated without being
enriched with significantly expressed genes, for example
in case of post-translational regulation. For example, the
three apoptosis related pathways identified in this analy-
sis showed little differential expression, however given
the number of other pathways it connects through via
differentially expressed genes might indicate they may
play a role in the context of this dataset. Finally, since
genes and proteins often participate in different path-
ways and may have diverse functions, looking at indivi-
dual pathway diagrams or lists of enriched pathways can
be confusing or even misleading. Our method provides
insight in the multiple roles of a protein in the context
of the studied dataset. In the case where a gene is differ-
entially expressed and also interacts with differentially
expressed genes in multiple pathways, this will typically
show up in the pathway interaction network, indicating
that it acts on the verge of different pathways.
Besides several advantages, we also identified several
possible improvements that may be made to this
approach. False positive pathway interactions were iden-
tified on occasion. One cause can be falsely annotated
interactions between proteins in the input interaction
network. This is the main reason we already excluded
associations based on text-mining only from the
STRING database, however remaining data may still
contain false associations. For example, the component
of metabolic pathways positioned around the Primary
bile acid biosynthesis pathway turned out to be a false
result after close inspection, due to falsely associated
enzymes in the STRING database. Over time, the quality
of interaction resources will probably improve, also
helped by curation initiatives such as WikiPathways.
Another cause of false or misleading results is the het-
erogeneity of many of the pathways. Pathway databases
often include context specific pathways, which provide a
summary of processes that are relevant to a specific dis-
ease or cell type or down-stream signaling of a specific
messenger. However, the processes included in these
pathways are often generic and play a role in other con-
texts as well, so finding an interaction with such a path-
way does not automatically mean that its context is also
relevant to the studied data. For example, we identified
several interactions with the ESC Pluripotency pathway,
which summarizes several signaling cascades regulating
pluripotency in embryonic stem cells. It is very unlikely
that embryonic stem cell functioning plays a role in our
dataset, but still several interactions with this pathway
were identified. These turned out to involve only speci-
fic parts of the signaling cascades, especially part of the
Wnt signaling pathway. This is also a common problem
in enrichment analysis, and our method does not pro-
vide a solution yet. Using a set of smallest generic core
pathways with as little overlap as possible might lead to
cleaner results. Possible alternative sources of pathway
information that might provide better results than the
databases used here could be Gene Ontology [34] or
Reactome [35], which provide hierarchical gene sets and
pathways, allowing us to move down in the hierarchy to
more specific modules if necessary. However, this would
require adaptations to the methodology in order to deal
with this hierarchical structure. Altogether, these points
show that the analysis approach presented here is
mostly useful for exploratory analysis and offers only
limited statistical proof for any of the findings. However,
in the broader investigation of complex data towards
more specific questions and testable hypothesis, this
method provides a unique way to explore the data in a
biological context.
The main shortcoming of using only transcriptomics
datasets in pathway-based approaches is that these pro-
vide insight in changes at the mRNA level only. In this
study, each identified pathway interaction is based on the
assumption that if a group of interacting genes is consis-
tently differentially expressed it is likely that changes are
reflected at the protein level as well. However, this may
not always be the case and it is not possible to investigate
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beyond this assumption using such datasets. In addition,
a large part of signaling and pathway cross-talk probably
works at a different level, through protein activation by
phosphorylation or other post-translational (or post-tran-
scriptional) regulatory mechanisms. If such interactions
play a role, they cannot be identified with this dataset
unless the interaction involves gene expression changes
as well. The interactions that are most relevant to this
dataset are transcriptional regulation, but unfortunately
our interaction network contains relatively few transcrip-
tion factor targets and we were unable to find a resource
to increase this number in addition to the PAZAR data-
base [36] used in this study. Despite this shortcoming, we
were still able to show that it allows finding several rele-
vant pathway interactions that help focus follow-up
experiments.
Although in this particular study we used a transcrip-
tomics dataset only, the method described here can
directly be applied to other types of data or combina-
tions of different data types as well. The method
requires an edge weight for each interaction, which can
be derived in different ways, depending on the type of
interaction and available data. For example, the interac-
tion network could be extended using the STITCH
database [37], which defines interactions between che-
micals and proteins. Thereby metabolomics data could
be incorporated by providing weights for these interac-
tions based on the metabolite abundance. In case both
protein and metabolite abundance is measured, a weight
could be calculated by combining the (differential)
abundances of the two interaction participants, for
example by taking the average. In addition, some types
of data can even be used to define more specific edge
weights, depending on what action the interaction repre-
sents. For example, if protein kinase activity measure-
ments are available, this data could be used to obtain
more accurate edge weights of specific protein interac-
tions that represent activation. This could then even be
combined with proteomics data to incorporate protein
abundance in the edge weights as well and thereby
obtaining more specific interactions by narrowing down
the possible substrates of a protein kinase. Future pub-
licly available datasets might cover these types of data at
a larger scale and the method described here may prove
useful in analyzing this complex data at a functional
level. To this end, all scripts and input data used for
this analysis are open-source and freely available (see
Additional file 3).
Conclusions
We designed an analysis approach to identify interac-
tions between biological pathways in a specific context.
By applying this method to a transcriptomics dataset,
we identified relevant pathway interactions and possible
key proteins involved in pathway cross-talk in the con-
text of insulin resistant mouse liver, and at specific time
points following a glucose challenge response. In addi-
tion, the analysis approach presented here can be
applied to different types of high-throughput data and
will be of more general use to facilitate interpretation of
other complex datasets.
Methods
Microarray experiment design
The gene expression microarray data from the NuGO
Proof of Principle Study 2 [8] was used. In this experi-
ment, C57BL/6J mice were fed two different diets for 12
weeks, containing either 10% (LF) or 45% (HF) fat by
energy. Animals fed the HF diet had developed insulin
resistance by the end of this feeding trial. After 12
weeks, both diet groups were subjected to a glucose tol-
erance test and liver tissue was removed 0, 0.6, 2 and 48
hours after the glucose challenge and hybridized to
NuGO Affymetrix Mouse GeneChip arrays
(NuGO_Mm1a520177). The resulting dataset consists of
8 biological replicates per diet and time point (totalling
64 samples). The data was normalized using the GC-
robust multi-array analysis (GCRMA) algorithm [38]
and probesets were redefined and annotated to Entrez
Gene identifiers using the Custom CDF version 11.0.2
[39]. Full details of the experiment and preprocessing of
the microarrays are described in more detail elsewhere
[8,12]. The resulting microarray dataset is available from
the ArrayExpress repository (http://www.ebi.ac.uk/
arrayexpress, accession number: E-MTAB-601).
Microarray gene-level statistics
The different groups were statistically compared using
the limma R package [40]. To study the initial difference
between the two diets, before the glucose challenge, we
tested for differential expression between HF and LF
groups at t = 0. To study the response to the glucose
challenge, we tested for differential expression between t
= 0 and each other time point in the HF and LF groups.
This resulted in the following statistics:
THF vs LF, t = 0: The moderated t-statistic, representing
the significance and direction of differential expression
between the HF and LF group at t = 0.
TLF, tx vs t0: The moderated t-statistic, representing the
significance and direction of differential expression
between each time point after the challenge (t = 0.6, t =
2 or t = 48) and the time point just before the challenge
(t = 0) in the LF group.
THF, tx vs t0: The moderated t-statistic, representing the
significance and direction of differential expression
between each time point after the challenge (t = 0.6, t =
2 or t = 48) and the time point just before the challenge
(t = 0) in the HF group.
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Based on the corresponding p-values as provided by
the limma package, q-values were calculated using the
qvalue package [41] to correct for multiple testing.
Pathways
Pathways from WikiPathways (analysis collection,
v2010-12-07) [10] and KEGG (v2010-06-14) [11] were
used. Pathways categorized under “Human diseases” at
the KEGG website were excluded from the analysis.
Pathways with high overlap in protein content were
merged into a single pathway using a step-wise proce-
dure:
1. Calculate overlap between each pathway pair.
2. For each pathway, find other pathways that have >
= 75% overlap and merge it with the most overlap-
ping pathway.
3. Repeat step 1-2 until no pathway pair with > =
75% overlap is left.
This merging step was performed because pathways
were combined from two different resources that partly
overlap, so different pathways that actually represent the
same underlying biological mechanism may occur.
Pathway enrichment
To find pathways that are enriched with genes that
score high in the differential expression test, the gene-
SetTest from the limma package was used. This test cal-
culates a test statistic for each pathway by taking the
mean of the absolute T-statistic of the genes in the
pathway and calculates P-values by comparing the test
statistic to an empirical null distribution based on
10,000 permutations with random gene sets. The result-
ing p-value for each pathway represents the significance
of its enrichment with differentially expressed genes,
regardless of their direction.
Interaction network
The interaction network used in this study combines the
following databases:
- Protein functional associations from the STRING
database (v8.3) [15]. This database aggregates interac-
tions from several protein-protein interaction reposi-
tories and pathway databases. Interactions based on text
mining alone and those with a confidence score < 0.4
were excluded.
- Transcription factor targets from the PAZAR data-
base (v2010-08-15) [36].
- Manually curated reactions and interactions from
the pathways described in the section ‘pathways’.
These interactions were merged into a single directed
network. For interactions without a defined direction
(e.g. binding), two directed edges in opposite direction
were added.
Gene and protein identifier mapping
Genes and proteins were mapped to a common database
using the BridgeDb library [42] and accompanying syno-
nym databases. All probesets in the transcriptomics
dataset and genes and proteins in the interaction net-
work were mapped to Ensembl gene identifiers using
the Mm_Derby_20090720.bridge database. These
mapped gene and protein identifiers will be referred to
as xref in the following description of the algorithm.
Finding interactions between pathways
To find possible interactions between pathways, we
started by generating a unified graph, integrating the
pathway and interaction information:
1. A graph GPX containing both the xref interactions
and pathway-xref associations was created and reused
for each group comparison. This graph contains two
types of nodes, either representing an xref or a pathway.
Edges were added between the xref nodes based on the
interaction network. In addition, each pathway node was
connected to each of the xref nodes that are associated
with that pathway.
Then the following steps were followed for each group
comparison separately:
2. Edge weights were calculated for GPX, based on the
gene-level statistics described in the section ‘Microarray
gene-level statistics’. First, a transformation using a sig-
moid function was applied to the T statistic:
f (T) = 1− 1
1 + e−α(|T|−μ)
This function ensures that the transformed values will
range from 0 to 1 and results in a soft threshold (Addi-
tional file 1, Figure S16), where the μ determines the
center of the threshold (the T value that will receive a
weight of 0.5) and a determines the steepness of the
curve (a higher a will result in a sharper cutoff). To
transform the T statistic, μ = 3 and a = 2 were used.
These parameters were chosen to emphasize genes with
an absolute T statistic > = 3 (corresponding to unad-
justed p-value < = 0.004) by receiving a lower weight.
Secondly, edge weights were assigned based on the
transformed T statistic f(T) of the target xref nodes they
connect to, or to the maximum value of 1 if no data
was available for the target xref. If the target of an edge
was a pathway node, the weight was set to 0. This way,
for each edge, the weight value inversely depends on the
value of the T statistic of the target gene, receiving a
low weight value if the gene is differentially expressed.
Thereby, paths that include genes (or the proteins they
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encode for) that are differentially expressed will have a
shorter length.
3. For each pathway node Pn in GPX a subgraph GPn
was created containing only nodes that could be reached
within nb steps (visited edges) from Pn. In this study,
parameter nb was set to 5, limiting the number of edges
between xref nodes in a path to maximal three. This
limit was introduced mainly to reduce calculation time.
Based on the distribution of resulting path lengths,
increasing nb is unlikely to have a large effect, as only a
single path with three edges between xref nodes had a
weighted length <lmax.
4. For each pathway node Pm in GPn another sub-
graph was created containing nodes Pn, Pm, the direct
neighbors of Pn and Pm (the xrefs in these pathways)
and all xref nodes that are not direct neighbors of a
pathway node (xrefs that are not in any pathway).
Excluding xref nodes that are present in pathways other
than Pm and Pn is necessary to prevent detection of
false interactions between Pn and Pm that cross other
pathways. Such an interaction should not be represented
as direct interaction between Pn and Pm, but rather as
two interactions with the other pathway as intermediate
between Pn and Pm. For xref nodes that were connected
to both Pn and Pm, the edge to Pm was removed to
prevent paths to go directly through an overlapping xref
(Figure 4).
5. The shortest path between Pn and Pm in GPn was
found, taking into account the edge weights (the length
of a path is the sum of its edge weights). The path
length was stored and the edges of the path, except
those that connect Pn or Pm, were deleted from GPn
(Figure 1C).
6. Step 5 was repeated until a preset maximum path
length lmax was reached (Figure 1C). The parameter lmax
controls how large the sum of the weights in a path
may be in order to contribute to the score between two
pathways. A larger lmax will allow more interactions
involving less significantly changed genes and result in
more (but potentially less interesting) interactions, while
a smaller lmax will have the reverse effect and only
include interactions with highly significantly changed
genes. In this study, lmax was set to 0.9, ensuring that
paths between xrefs with low significance or no mea-
sured data (which will have a weight close to 1, see step
2) do not contribute to the interaction score.
7. For each pathway pair PnPm a list of path lengths li
is now available. These were converted to a single inter-
action score SPnPm for each pathway pair by calculating
the sum of the inverted lengths:
Spnpm =
∑
i
1
li
8. Significance of the interaction was calculated by
comparing the interaction score to an empirical null dis-
tribution. This null distribution was generated by
repeating step 3-7 to recalculate an interaction score
between Pn and Pr (a randomized version of Pm),
resulting in a collection of randomized interaction
scores SPnPr. For each permutation, Pr was generated by
reconnecting the endpoints of its adjacent edges (which
are the nodes representing the xrefs associated to the
pathway) to different xref nodes from the interaction
network that have a similar strength (also weighted
degree [43]) as the original xref node. This way, the ran-
domized pathway has a connectivity that is similar to
the original pathway. Empirical p-values were calculated
for each pathway pair by counting the number of times
SPnPr is higher or equal to SPnPm and dividing this by
the number of permutations. Firstly, p-values for each
pathway pair were calculated using 100 permutations.
Secondly, the resolution of the p-value of potentially sig-
nificant pathway pairs was increased by adding another
1000 permutations for pairs that had a p-value < 0.1
after 100 permutations.
E
A
P2
D
B
P1
C
A.
P4
J
I
P3
M
H
G
L
B.
Figure 4 Two examples of overlap between pathways with
respect to the algorithm for finding pathway interactions. Red
nodes are proteins that are present in both pathways, dashed
edges will be removed before finding shortest paths. A: A pathway
pair with one overlapping protein (protein A) which connects to
distinct paths within the two pathways. The overlap itself is not
counted as interaction between the pathways, but by removing
only the dashed edge A still acts as an indirect intermediate to
establish a path between P1 and P2 via proteins B and E. B: A
pathway pair which shares two proteins that do not connect to
distinct paths within each pathway. In this case these proteins do
not contribute to the pathway interaction, because the dashed
edges are removed.
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This algorithm was implemented in the statistical
language R [44] and uses the igraph package [45] for
handling graph structures and finding shortest paths
between two nodes. The R source code and utility
scripts to generate and format the data are available as
Additional file 3.
To reduce the contribution of overlapping proteins
between pathways to the interactions between path-
ways, the edge from an overlapping protein to one of
the pathways in a pair is removed in step 4. While
pathways with more than 75% overlap were merged,
some pathways might still have much overlap that may
outweigh the influence of pathway interactions via pro-
tein interactions. However, to completely discard over-
lapping genes might be too conservative, since an
overlapping protein may be a key regulator that might
connect two distinct parts of the different pathways.
For example, in Figure 4A, two pathways both contain
protein A, which connects to a distinct path in each
pathway. If protein A would be excluded from the ana-
lysis (as in Li et al. [6]), a relevant interaction between
the two distinct paths will be missed. However, in Fig-
ure 4B, two pathways share a complete path of three
proteins which does not connect to any other distinct
part within each pathway and hence these proteins are
unlikely to contribute to an interaction between the
pathways. In this case, our approach of removing one
of the edges with the pathway will give equal results as
excluding the proteins.
Network analysis and visualization
All networks were visualized using Cytoscape [13]. Net-
work properties such as average path length, clustering
coefficient, node degree and betweenness centrality were
calculated using the igraph library in R. Betweenness
centrality as displayed in Additional file 1, Figure S3 was
normalized by dividing the value calculated with the
igraph function betweenness by the maximum centrality,
which is the total number of node pairs in the network,
excluding the node for which the betweenness centrality
is calculated.
Additional material
Additional file 1: Supplementary figures and tables. Contains the
supplementary figures and tables.
Additional file 2: Cytoscape visualization of pathway interaction
networks. Contains the cytoscape session files with interactive
visualizations of the pathway interaction networks. These can be viewed
with the freely available Cytoscape software http://www.cytoscape.org/.
Additional file 3: Scripts and input data. Contains instructions on how
to obtain the scripts, utilities and formatted input data that was used in
this analysis.
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